Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 12
Submit an article Journal homepage
282
Views
10
CrossRef citations to date
0
Altmetric
Oncology

A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma

Akeem A. YusufChronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA; ;Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, MN, USA; Correspondence[email protected]
,
Tanya NatwickChronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA;
,
Winifred WertherOnyx Pharmaceuticals Inc., an Amgen Subsidiary, South San Francisco, CA, USA
,
Diana FeliciOnyx Pharmaceuticals Inc., an Amgen Subsidiary, South San Francisco, CA, USA
,
Maya MahueOnyx Pharmaceuticals Inc., an Amgen Subsidiary, South San Francisco, CA, USA
,
Kenneth R. BridgesOnyx Pharmaceuticals Inc., an Amgen Subsidiary, South San Francisco, CA, USA
&
Yi PengChronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA;
show all
Pages 1989-1996 | Received 15 Apr 2016, Accepted 15 Aug 2016, Published online: 16 Sep 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Chun-Kuang Tsai, Leh-Kiong Huon, Shuo-Ming Ou, Ai-Seon Kuan, Chiu-Mei Yeh, Yu-Ting Lee, Yao-Chung Liu, Tzeng-Ji Chen, Jin-Hwang Liu & Chia-Jen Liu. (2017) Risk and impact of tuberculosis in patients with multiple myeloma*. Leukemia & Lymphoma 58:11, pages 2598-2606.
Read now

Articles from other publishers (9)

Lorris Lecot, Isabelle Desmas‐Bazelle, Sarah Benjamin, Pauline De Fornel, Frédérique Ponce, Matthew Kornya, Loïc Desquilbet, Claire Beaudu‐Lange, Catherine Ibisch, David Sayag, Ghita Benchekroun & Jérémy Béguin. (2024) Descriptive analysis and prognostic factors in cats with myeloma‐related disorders: A multicenter retrospective study of 50 cases. Journal of Veterinary Internal Medicine 38:3, pages 1693-1705.
Crossref
Maria-Victoria Mateos, Sikander Ailawadhi, Luciano J. Costa, Shakira J. Grant, Lalit Kumar, Mohamad Mohty, Didem Aydin & Saad Z. Usmani. (2023) Global disparities in patients with multiple myeloma: a rapid evidence assessment. Blood Cancer Journal 13:1.
Crossref
Haris Hatic, Shealeigh Inselman, Jonathan Inselman, Anuhya Kommalapati, Sri Harsha Tella, Jonas Paludo, Urshila Durani, Ronald S. Go & Gaurav Goyal. (2022) Time to first treatment is an independent prognostic factor for Multiple Myeloma (MM). Leukemia Research 123, pages 106966.
Crossref
Esma Evrim Dogan, Aysenur Arslan, Naciye Demirel, Demet Aydin, Ilknur Mansuroglu, Suheyla Atak, Fatma Keklik Karadag, Rafet Eren & Guray Saydam. (2022) Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival. Bulletin of the National Research Centre 46:1.
Crossref
Li Bao, Yutong Wang, Minqiu Lu, Bin Chu, Lei Shi, Shan Gao, Lijuan Fang & Qiuqing Xiang. (2020) Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients. Cancer Medicine 9:23, pages 8962-8969.
Crossref
Rafael Ríos-Tamayo, Dolores Sánchez Rodríguez, Yoe-Ling Chang- Chan & María-José Sánchez Pérez. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Nancy A. Brandenburg, Syd Phillips, Karen E. Wells, Kimberley J. Woodcroft, Kandace L. Amend, Cheryl Enger & Susan A. Oliveria. (2019) Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review. Pharmacoepidemiology and Drug Safety 28:2, pages 256-263.
Crossref
Ricardo Fernández & Esther Chon. (2018) Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs. Journal of Veterinary Internal Medicine 32:3, pages 1060-1069.
Crossref
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, Evangelos Terpos, Eirini Katodritou, Argiris Symeonidis, Sosana Delimpasi, Anastasia Pouli, Theodoros P. Vassilakopoulos, Eurydiki Michalis, Stavroula Giannouli, Zafiris Kartasis, Anna Christoforidou, Kiriaki Kokoviadou, Eleftheria Hatzimichael, Dimitra Gika, Catherine Megalakaki, Maria Papaioannou, Marie‐Christine Kyrtsonis, Kostas Konstantopoulos & Meletios A. Dimopoulos. (2017) Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies. European Journal of Haematology 99:5, pages 409-414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.